Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates ...
By Laurie Chen SHANGHAI, July 23 (Reuters) - Hong Kong-listed Insilico Medicine has cut drug development timelines to about ...
New Scientist on MSN
Drug discovery is changing. Drug development must change too.
In this New Scientist CoLab podcast, experts from global life sciences leader Cytiva explain the hidden, high-stakes science of purification that is required to close the gap between drug discovery ...
Discover how AI-powered analytics and experimental validation combine to improve target identification and accelerate drug ...
Despite ongoing advancements in genomics, artificial intelligence, and precision medicine, clinical trial success rates have ...
Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is ...
The Pulse Report highlights AI's expanding role in drug discovery, biomarker identification, clinical trial optimization and ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
Bristol Myers Squibb is buying Nvidia’s Vera Rubin system to speed drug discovery, with lessons for South Africa’s ...
New capabilities unify Certara's biosimulation software, products, datasets, and scientific expertise with AI-driven agents to deliver specialized insights for life sciences ...
The drugmaker will deploy NVIDIA's Vera Rubin systems, giving it what it calls the most powerful AI computing infrastructure ...
SHANGHAI: Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results